BioCentury
ARTICLE | Top Story

Symphogen raises EUR 100 million

January 7, 2011 1:37 AM UTC

Symphogen A/S (Copenhagen, Denmark) raised EUR 100 million ($132.9 million) in a series E round led by Novo A/S. New investor Danish Pension Fund PKA and existing investor Essex Woodlands Health Ventures also participated. Symphogen also appointed Goran Ando as chairman. Ando is the former CEO of Celltech Group plc. ...